Clinical and Microbiological Effects of a Mouthwash Containing Chlorine Dioxide
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Previous research has shown the oxidizing properties and microbiological efficacies of chlorine dioxide (ClO2). However, no clinical studies have investigated its microbiological efficacies on periodontal and malodorous bacteria. The aim of this study was to assess the inhibitory effects of a mouthwash containing ClO2 on morning oral malodor and on salivary periodontal and malodorous bacteria using for 7 days.
| Condition | Intervention | Phase |
|---|---|---|
|
Halitosis |
Other: Chlorine Dioxide |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety Study Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Outcomes Assessor) Primary Purpose: Prevention |
| Official Title: | The Clinical Effects of a Mouthwash Containing Chlorine Dioxide on Oral Malodor and Salivary Periodontal and Malodorous Bacteria Using for 7days |
- Oral malodor [ Time Frame: 7 days ] [ Designated as safety issue: Yes ]
- Periodontal bacteria [ Time Frame: 7 days ] [ Designated as safety issue: Yes ]
| Enrollment: | 15 |
| Study Start Date: | March 2007 |
| Study Completion Date: | June 2007 |
| Primary Completion Date: | May 2007 (Final data collection date for primary outcome measure) |
-
Other: Chlorine Dioxide
Background: Previous research has shown the oxidizing properties and microbiological efficacies of chlorine dioxide (ClO2). Its clinical efficacies on oral malodor have been evaluated and reported, however, no clinical studies have investigated its microbiological efficacies on periodontal and malodorous bacteria. The aim of this study was to assess the inhibitory effects of a mouthwash containing ClO2 on morning oral malodor and on salivary periodontal and malodorous bacteria using for 7 days.
Methods: A randomized, double blind, crossover, placebo-controlled clinical trial was conducted among 15 healthy male volunteers, who were divided into 2 groups. In the first test phase, the group 1 subjects (N = 8) were instructed to rinse with the experimental mouthwash containing ClO2 twice per day for 7 days, and those in group 2 (N = 7) to rinse with the control (placebo) mouthwash without ClO2. In the second test, phase after a one week washout period, each group had used the opposite mouthwash for 7 days. At baseline and after 7 days, oral malodor was evaluated with OM, and concentrations of hydrogen sulfide (H2S), methyl mercaptan (CH3SH) and dimethyl sulfide ((CH3)2S), the main VSCs of human oral malodor, were evaluated with GC. Clinical outcome variables included plaque and gingival indices, and the Winkel Tongue Coating Index(WTCI). The samples of saliva were microbiologically investigated.
Outcome variables were compared by t-test and Mann-Whitney test.
Eligibility| Ages Eligible for Study: | 19 Years to 38 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Clinical diagnosis of oral malodor
Exclusion Criteria:
- Oral malodor caused by foods
Contacts and Locations
More Information
No publications provided by Tokyo Medical and Dental University
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Kayoko Shinada/DDS, phD, Dept. of Oral health promotion, Tokyo medical and dental university |
| ClinicalTrials.gov Identifier: | NCT00748943 History of Changes |
| Other Study ID Numbers: | 2_Shinada, 2_Shinada |
| Study First Received: | September 8, 2008 |
| Last Updated: | September 11, 2008 |
| Health Authority: | Japan: Ministry of Education, Culture, Sports, Science and Technology |
Keywords provided by Tokyo Medical and Dental University:
|
chlorine dioxide mouthwash |
halitosis bacteria saliva |
Additional relevant MeSH terms:
|
Halitosis Signs and Symptoms, Digestive Signs and Symptoms Chlorine dioxide Dental Disinfectants |
Disinfectants Anti-Infective Agents Therapeutic Uses Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 22, 2013